NASDAQ: BNGOBionano Genomics Inc Stock Ownership - Who owns Bionano Genomics?
Insider buying vs selling
Have Bionano Genomics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alka Chaubey | CHIEF MEDICAL OFFICER | 2024-02-15 | 1,081 | $1.27 | $1.37kSell |
| Jonathan V. Dixon | GENERAL COUNSEL | 2024-02-15 | 402 | $1.27 | $510.54Sell |
| R. Erik Holmlin | PRESIDENT AND CEO | 2024-02-15 | 3,073 | $1.27 | $3.90kSell |
| Mark Oldakowski | CHIEF OPERATING OFFICER | 2024-02-15 | 1,229 | $1.27 | $1.56kSell |
| Hannah Mamuszka | Director | 2023-06-13 | 65,789 | $0.76 | $50.00kBuy |
| R. Erik Holmlin | President and CEO | 2023-05-16 | 15,000 | $0.64 | $9.65kBuy |
| Christopher P. Stewart | Chief Financial Officer | 2023-05-12 | 50,000 | $0.67 | $33.40kBuy |
| Mark Oldakowski | Chief Operating Officer | 2023-05-12 | 41,496 | $0.66 | $27.39kSell |
| R. Erik Holmlin | President and CEO | 2023-05-12 | 50,141 | $0.66 | $33.09kSell |
BNGO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BNGO insiders and whales buy or sell their stock.
BNGO Shareholders
What type of owners hold Bionano Genomics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| LC Fund Vi LP | 10.36% | 5,668,017 | $4.85M | Insider |
| Junfeng Wang | 10.36% | 5,668,017 | $4.85M | Insider |
| Quan Zhou | 10.36% | 5,668,017 | $4.85M | Insider |
| Soheil Shams | 9.15% | 5,006,479 | $4.29M | Insider |
| Vanguard Group Inc | 3.46% | 1,893,645 | $1.62M | Institution |
| Rosy Shine Ltd | 2.07% | 1,134,000 | $970.70k | Insider |
| Wealth Strategy Holding Ltd | 1.78% | 975,000 | $834.60k | Insider |
| Domain Partners Viii LP | 1.73% | 943,878 | $807.96k | Insider |
| Gmt Capital Corp | 0.97% | 530,254 | $453.90k | Institution |
| Renaissance Technologies LLC | 0.94% | 514,230 | $440.18k | Institution |
BNGO vs Medical Stocks
Bionano Genomics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.